- Home
- TOPS vs INKT Comparison
TOPS vs INKT Comparison
Compare TOPS & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOPS
- INKT
- Stock Information
- Founded
- TOPS 2000
- INKT 2017
- Country
- TOPS Greece
- INKT United States
- Employees
- TOPS N/A
- INKT N/A
- Industry
- TOPS Marine Transportation
- INKT Medicinal Chemicals and Botanical Products
- Sector
- TOPS Consumer Discretionary
- INKT Health Care
- Exchange
- TOPS Nasdaq
- INKT Nasdaq
- Market Cap
- TOPS 28.3M
- INKT 34.9M
- IPO Year
- TOPS 2004
- INKT 2021
- Fundamental
- Price
- TOPS $6.12
- INKT $12.03
- Analyst Decision
- TOPS
- INKT Strong Buy
- Analyst Count
- TOPS 0
- INKT 2
- Target Price
- TOPS N/A
- INKT $6.50
- AVG Volume (30 Days)
- TOPS 10.1K
- INKT 43.7K
- Earning Date
- TOPS 03-28-2025
- INKT 03-20-2025
- Dividend Yield
- TOPS N/A
- INKT N/A
- EPS Growth
- TOPS N/A
- INKT N/A
- EPS
- TOPS N/A
- INKT N/A
- Revenue
- TOPS $83,870,000.00
- INKT N/A
- Revenue This Year
- TOPS $7.10
- INKT N/A
- Revenue Next Year
- TOPS $6.54
- INKT N/A
- P/E Ratio
- TOPS N/A
- INKT N/A
- Revenue Growth
- TOPS 1.10
- INKT N/A
- 52 Week Low
- TOPS $5.30
- INKT $4.56
- 52 Week High
- TOPS $14.94
- INKT $19.00
- Technical
- Relative Strength Index (RSI)
- TOPS 35.63
- INKT 63.62
- Support Level
- TOPS $6.11
- INKT $4.56
- Resistance Level
- TOPS $6.44
- INKT $10.70
- Average True Range (ATR)
- TOPS 0.39
- INKT 1.82
- MACD
- TOPS -0.07
- INKT 0.11
- Stochastic Oscillator
- TOPS 2.29
- INKT 82.54
About TOPS TOP Ships Inc.
TOP Ships Inc owns tanker vessels throughout the world. The company focuses on the transportation of petroleum products (clean and dirty) and bulk liquid chemicals. The Company is an international provider of worldwide oil, petroleum products and chemical transportation services. It generates revenue from the Time Charter agreements.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.